EphMRA Annual Conference 2019
25-27 June 2019 Warsaw, Poland
We are delighted to be sponsoring, exhibiting and presenting three papers at this year’s EphMRA Annual Conference in Warsaw, Poland 25-27 June. Representing Research Partnership are Director and EphMRA Board Member Richard Head, Director Paula Coyle, and Associate Director Emilie Braund. Also in attendance will be Associate Director An-hwa Lee who sits on the EphMRA Learning and Development Committee, which plans to convene before the conference begins.
Intellus Worldwide Summit round up 2019
This May, Liza Pliss, Director and Head of our New York Office, Sabera Hyderally, Director, Head of MedTech Division North America and Emily Hoffman, Associate Director exhibited at and attended the Intellus Worldwide Summit in Philadelphia.
Intellus Worldwide Summit 2019
Visit us at stand 311
We are delighted to be exhibiting at the Intellus Worldwide Summit in Philadelphia, USA from 19th-21st May. Representing Research Partnership at the event will be Liza Pliss, Director and Head of our New York Office, Sabera Hyderally, Director, Head of MedTech Division North America and Emily Hoffman, Associate Director.
PMRC New Jersey round up 2019
Earlier this month, Director, Head of New York office, Liza Pliss and Associate Director, Emily Hoffman attended the Pharmaceutical Market Research Conference in Newark, New Jersey.
Liza Pliss and Cornelia Fuller, US Lead at Sanofi also co-presented the paper, ‘Optimizing your Digital Assets with UX Research.’ In this presentation, they discussed the topic of User Experience (sometimes referred to as UX) and Usability specifically as they relate to digital assets (such as websites, apps, and other digital tools). They covered what UX is, why it is important, and walked through a case study, focusing on a specific UX tool that was used to help design a website.
How we helped track and evaluate conference performance over time across multiple international events
Our client planned to have a significant presence at key global conferences over the course of a year. Find out how we effectively monitored perceptions of their brand across different regions over time.
Our client was developing a portfolio for the treatment of a chronic neurodegenerative disease and planned to have a significant presence at key neuroscience conferences over the coming year. With conferences being a considerable investment, they wanted to understand how various aspects of their presence and presentations n(vs competitors) at each event impacted their target.